Pharmac Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 25 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -5.29%
- Ebitda 74.86%
- Net Worth -2.82%
- Total Assets -0.07%
About Pharmac Technologies
Pharmac Technologies Private Limited (PTPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 May 1999 and has a history of 25 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Bhagade, Swapnil Bhagade, and Meeta Mashru serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110MH1999PTC120114
- Company No.
120114
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Pharmac Technologies Private Limited offer?
Pharmac Technologies Private Limited offers a wide range of products and services, including Water Treatment & Purification Plant, Water Treatment Plants, Chemical Plants & Machinery, Distillation Units.
Who are the key members and board of directors at Pharmac Technologies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Bhagade  | Director | 31-May-1999 | Current |
| Swapnil Bhagade | Director | 31-May-1999 | Current |
| Meeta Mashru | Director | 31-May-1999 | Current |
Financial Performance of Pharmac Technologies.
Pharmac Technologies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 5.29% decrease in profit. The company's net worth dipped by a decrease of 2.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmac Technologies?
In 2021, Pharmac Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmac Technologies?
Unlock and access historical data on people associated with Pharmac Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmac Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmac Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.